Article Information
History
- May 12, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Dirk Jan A.R. Moes, (PharmD, PhD)1,2,*,
- David J. van Westerloo, (MD, PhD)3,
- Sandra M. Arend, (MD, PhD)4,
- Jesse J. Swen, (PharmD, PhD)1,2,
- Annick de Vries, (PhD)5,
- Henk-Jan Guchelaar, (PharmD, PhD)1,2,
- Simone A. Joosten, (PhD, PhD)4,
- Mark G.J. de Boer, (MD, PhD)4,
- Teun van Gelder, (MD, PhD)1,2 and
- Judith van Paassen, (MD)3
- 1Leiden University Medical Center, Department of Clinical Pharmacy and Toxicology, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands
- 2Leiden Network for Personalised Therapeutics, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands
- 3Leiden University Medical Center, Department of Intensive Care, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands
- 4Leiden University Medical Center, Department of Infectious Diseases, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands
- 5Biologics Lab, Sanquin Diagnostic Services, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands
- ↵*CORRESPONDING AUTHOR
Dr. D.J.A.R. Moes, PharmD, PhD, Hospital Pharmacist Laboratory (TDM/Toxicology) / Assistant Professor of Applied Clinical Pharmacometrics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands, Department of Clinical Pharmacy and Toxicology, Email: D.J.A.R.Moes{at}lumc.nl, Telephone: +31 715297960 / +31643052862, Fax: +31 715266106